AbCellera Biologics Inc. (FRA:8QQ)
Germany flag Germany · Delayed Price · Currency is EUR
3.098
+0.098 (3.27%)
At close: Dec 5, 2025

AbCellera Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Cash & Equivalents
83.16156.33133.32386.54476.14594.12
Upgrade
Short-Term Investments
412.51469.29627.27499.95246.84-
Upgrade
Cash & Short-Term Investments
495.67625.61760.59886.49722.98594.12
Upgrade
Cash Growth
-22.93%-17.75%-14.20%22.62%21.69%7765.96%
Upgrade
Accounts Receivable
41.4633.6230.5938.59160.58213.24
Upgrade
Other Receivables
46.6626.5333.7964.8214.280.49
Upgrade
Receivables
159.3692.1364.38103.41174.86213.73
Upgrade
Inventory
---1.531.671.41
Upgrade
Prepaid Expenses
15.118.6322.029.065.294.07
Upgrade
Restricted Cash
2525252525-
Upgrade
Total Current Assets
695.14751.37871.991,025929.8813.33
Upgrade
Property, Plant & Equipment
427.36340.43287.7217.26111.6217.92
Upgrade
Long-Term Investments
93.382.365.9434.4232.3120.03
Upgrade
Goodwill
47.8147.8147.8147.8147.8131.5
Upgrade
Other Intangible Assets
39.3242.11120.43131.5148.39115.15
Upgrade
Long-Term Deferred Tax Assets
-----5.9
Upgrade
Other Long-Term Assets
53.0766.9480.3440.8330.641.71
Upgrade
Total Assets
1,3561,3611,4881,5411,3191,006
Upgrade
Accounts Payable
31.7734.3528.614.8314.927.32
Upgrade
Accrued Expenses
7.238.387.7125.826.5429.13
Upgrade
Current Portion of Leases
5.174.626.165.583.650.68
Upgrade
Current Income Taxes Payable
----35.6836.15
Upgrade
Current Unearned Revenue
24.6321.1826.0727.912.017.53
Upgrade
Other Current Liabilities
-8.0950.4844.2127.8722.68
Upgrade
Total Current Liabilities
68.876.61119.01118.32120.68103.49
Upgrade
Long-Term Leases
137.0560.7471.2276.6836.413.72
Upgrade
Long-Term Unearned Revenue
174.97155.59104.1160.3260.7625.89
Upgrade
Long-Term Deferred Tax Liabilities
9.7410.0530.6133.1837.3726.16
Upgrade
Other Long-Term Liabilities
1.391.4710.8219.1437.6215.77
Upgrade
Total Liabilities
391.95304.47335.78307.63292.84175.03
Upgrade
Common Stock
794.47777.17753.2734.37722.43710.39
Upgrade
Additional Paid-In Capital
192.8166.36121.0574.1235.365.92
Upgrade
Retained Earnings
-20.54116.93279.79426.19267.67114.2
Upgrade
Comprehensive Income & Other
-2.7-4.38-1.72-1.390.28-
Upgrade
Total Common Equity
964.041,0561,1521,2331,026830.51
Upgrade
Shareholders' Equity
964.041,0561,1521,2331,026830.51
Upgrade
Total Liabilities & Equity
1,3561,3611,4881,5411,3191,006
Upgrade
Total Debt
142.2265.3677.3882.2640.074.39
Upgrade
Net Cash (Debt)
353.45560.25683.21804.23682.91589.73
Upgrade
Net Cash Growth
-38.18%-18.00%-15.05%17.76%15.80%88982.48%
Upgrade
Net Cash Per Share
1.191.902.362.552.152.24
Upgrade
Filing Date Shares Outstanding
299.34297.99292.78287.69283.92269.5
Upgrade
Total Common Shares Outstanding
299.01295.76290.82286.85283.26269.5
Upgrade
Working Capital
626.34674.76752.97907.17809.12709.84
Upgrade
Book Value Per Share
3.223.573.964.303.623.08
Upgrade
Tangible Book Value
876.91966.17984.091,054829.54683.86
Upgrade
Tangible Book Value Per Share
2.933.273.383.672.932.54
Upgrade
Land
53.4153.4153.4153.4133.04-
Upgrade
Buildings
53.1152.9143.9511.361.21-
Upgrade
Machinery
97.1684.2973.8749.5626.6515.87
Upgrade
Leasehold Improvements
138.4122.8973.9440.5722.753.71
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.